Tolmar Therap patents expiration
1. Eligard Kit patents expiration
ELIGARD KIT's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US8470359 | TOLMAR THERAP | Sustained release polymer |
Oct, 2023
(23 days from now) | |
Drugs and Companies using LEUPROLIDE ACETATE ingredient
Market Authorisation Date: 24 July, 2002
Treatment: Method of treating cancer
Dosage: POWDER;SUBCUTANEOUS
More Information on Dosage
ELIGARD KIT family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic